These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 38401028)

  • 1. Survival Benefit of Myeloablative Therapy with Autologous Stem Cell Transplantation in High-Risk Neuroblastoma: A Systematic Literature Review.
    Żebrowska U; Balwierz W; Wechowski J; Wieczorek A
    Target Oncol; 2024 Mar; 19(2):143-159. PubMed ID: 38401028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.
    Yalçin B; Kremer LC; van Dalen EC
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD006301. PubMed ID: 26436598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.
    Yalçin B; Kremer LC; Caron HN; van Dalen EC
    Cochrane Database Syst Rev; 2013 Aug; (8):CD006301. PubMed ID: 23970444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin.
    Kushner BH; Ostrovnaya I; Cheung IY; Kuk D; Modak S; Kramer K; Roberts SS; Basu EM; Yataghene K; Cheung NK
    Oncotarget; 2016 Jan; 7(4):4155-66. PubMed ID: 26623730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults.
    Schaaf M; Reiser M; Borchmann P; Engert A; Skoetz N
    Cochrane Database Syst Rev; 2012 Jan; 1():CD007678. PubMed ID: 22258971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-GD2 antibody-containing immunotherapy postconsolidation therapy for people with high-risk neuroblastoma treated with autologous haematopoietic stem cell transplantation.
    Peinemann F; van Dalen EC; Enk H; Tytgat GA
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD012442. PubMed ID: 31016728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphoma.
    Rancea M; Monsef I; von Tresckow B; Engert A; Skoetz N
    Cochrane Database Syst Rev; 2013 Jun; (6):CD009411. PubMed ID: 23784872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-line tandem high-dose chemotherapy and autologous stem cell transplantation versus single high-dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies.
    Naumann-Winter F; Greb A; Borchmann P; Bohlius J; Engert A; Schnell R
    Cochrane Database Syst Rev; 2012 Oct; 10():CD004626. PubMed ID: 23076906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous Transplantation for Newly Diagnosed Multiple Myeloma in the Era of Novel Agent Induction: A Systematic Review and Meta-analysis.
    Dhakal B; Szabo A; Chhabra S; Hamadani M; D'Souza A; Usmani SZ; Sieracki R; Gyawali B; Jackson JL; Asimakopoulos F; Hari PN
    JAMA Oncol; 2018 Mar; 4(3):343-350. PubMed ID: 29302684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Autologous Stem-Cell Transplantation in High-Risk Neuroblastoma Consolidated by anti-GD2 Immunotherapy. Results of Two Consecutive Studies.
    Mora J; Castañeda A; Flores MA; Santa-María V; Garraus M; Gorostegui M; Simao M; Perez-Jaume S; Mañe S
    Front Pharmacol; 2020; 11():575009. PubMed ID: 33324208
    [No Abstract]   [Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.
    Yalçin B; Kremer LC; Caron HN; van Dalen EC
    Cochrane Database Syst Rev; 2010 May; (5):CD006301. PubMed ID: 20464740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose chemotherapy for Ewing sarcoma and Rhabdomyosarcoma: A systematic review by the Australia and New Zealand sarcoma association clinical practice guidelines working party.
    Ramamurthy A; Connolly EA; Mar J; Lewin J; Bhadri VA; Phillips MB; Winstanley M; Orme LM; Grimison P; Connor J; Lazarakis S; Hong AM; Omer N; Cayrol J
    Cancer Treat Rev; 2024 Mar; 124():102694. PubMed ID: 38325070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoic acid post consolidation therapy for high-risk neuroblastoma patients treated with autologous hematopoietic stem cell transplantation.
    Peinemann F; van Dalen EC; Tushabe DA; Berthold F
    Cochrane Database Syst Rev; 2015 Jan; 1():CD010685. PubMed ID: 25634649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoic acid postconsolidation therapy for high-risk neuroblastoma patients treated with autologous haematopoietic stem cell transplantation.
    Peinemann F; van Dalen EC; Enk H; Berthold F
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD010685. PubMed ID: 28840597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous stem cell transplantation in follicular lymphoma: a systematic review and meta-analysis.
    Al Khabori M; de Almeida JR; Guyatt GH; Kuruvilla J; Crump M
    J Natl Cancer Inst; 2012 Jan; 104(1):18-28. PubMed ID: 22190633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted immunotherapy for high-risk neuroblastoma--the role of monoclonal antibodies.
    Parsons K; Bernhardt B; Strickland B
    Ann Pharmacother; 2013 Feb; 47(2):210-8. PubMed ID: 23386066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and effectiveness of treatment strategy of tandem high-dose chemotherapy and autologous stem cell transplantation in combination with
    Suh JK; Koh KN; Min SY; Kim YS; Kim H; Im HJ; Namgoong JM; Kim DY; Ahn SD; Lee JJ; Seo JJ
    Pediatr Transplant; 2020 Mar; 24(2):e13658. PubMed ID: 31960542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes of the GPOH NB97 trial for children with high-risk neuroblastoma comparing high-dose chemotherapy with autologous stem cell transplantation and oral chemotherapy as consolidation.
    Berthold F; Ernst A; Hero B; Klingebiel T; Kremens B; Schilling FH; Simon T
    Br J Cancer; 2018 Aug; 119(3):282-290. PubMed ID: 29991700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous hematopoietic stem cell transplantation following high dose chemotherapy for non-rhabdomyosarcoma soft tissue sarcomas.
    Peinemann F; Smith LA; Bartel C
    Cochrane Database Syst Rev; 2013 Aug; 2013(8):CD008216. PubMed ID: 23925699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.